150 related articles for article (PubMed ID: 12496703)
1. Analysis of p53 and c-erbB-2 expression in ovarian endometrioid carcinomas arising in endometriosis.
Prefumo F; Venturini PL; Fulcheri E
Int J Gynecol Pathol; 2003 Jan; 22(1):83-8. PubMed ID: 12496703
[TBL] [Abstract][Full Text] [Related]
2. Ovarian carcinomas in endometriosis: an immunohistochemical and comparative genomic hybridization study.
Mhawech P; Kinkel K; Vlastos G; Pelte MF
Int J Gynecol Pathol; 2002 Oct; 21(4):401-6. PubMed ID: 12352189
[TBL] [Abstract][Full Text] [Related]
3. The role of p53 mutation in the carcinomas arising from endometriosis.
Akahane T; Sekizawa A; Purwosunu Y; Nagatsuka M; Okai T
Int J Gynecol Pathol; 2007 Jul; 26(3):345-51. PubMed ID: 17581423
[TBL] [Abstract][Full Text] [Related]
4. KRAS mutations in ovarian low-grade endometrioid adenocarcinoma: association with concurrent endometriosis.
Stewart CJ; Leung Y; Walsh MD; Walters RJ; Young JP; Buchanan DD
Hum Pathol; 2012 Aug; 43(8):1177-83. PubMed ID: 22305241
[TBL] [Abstract][Full Text] [Related]
5. Genomic imbalance and onco-protein expression of ovarian endometrioid adenocarcinoma arisen in an endometriotic cyst.
Noack F; Schmidt H; Buchweitz O; Malik E; Horny HP
Anticancer Res; 2004; 24(1):151-4. PubMed ID: 15015590
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of p53, EGFR, c-erbB2 and c-erbB3 in endometrioid carcinoma of the ovary.
Leng J; Lang J; Shen K; Guo L
Chin Med Sci J; 1997 Jun; 12(2):67-70. PubMed ID: 11324501
[TBL] [Abstract][Full Text] [Related]
7. [Pathogenic role of PTEN tumor suppressor gene in ovarian cancer associated to endometriosis].
Castiblanco G A; Pires N Y; Wistuba O I; Riquelme S E; Andrade M L; Corvalán R A
Rev Med Chil; 2006 Mar; 134(3):271-8. PubMed ID: 16676097
[TBL] [Abstract][Full Text] [Related]
8. Endometriosis-associated Ovarian Cancers.
Anglesio MS; Yong PJ
Clin Obstet Gynecol; 2017 Dec; 60(4):711-727. PubMed ID: 28990985
[TBL] [Abstract][Full Text] [Related]
9. Endometriosis does not confer improved prognosis in ovarian carcinoma of uniform cell type.
Cuff J; Longacre TA
Am J Surg Pathol; 2012 May; 36(5):688-95. PubMed ID: 22498820
[TBL] [Abstract][Full Text] [Related]
10. Possible involvement of loss of heterozygosity in malignant transformation of ovarian endometriosis.
Xu B; Hamada S; Kusuki I; Itoh R; Kitawaki J
Gynecol Oncol; 2011 Feb; 120(2):239-46. PubMed ID: 21130491
[TBL] [Abstract][Full Text] [Related]
11. Immunophenotypic analysis of ovarian endometrioid adenocarcinoma: correlation with KRAS mutation and the presence of endometriosis.
Stewart CJ; Walsh MD; Budgeon CA; Crook ML; Buchanan DB
Pathology; 2013 Oct; 45(6):559-66. PubMed ID: 24018808
[TBL] [Abstract][Full Text] [Related]
12. Increased prevalence of p53 overexpression from typical endometriosis to atypical endometriosis and ovarian cancer associated with endometriosis.
Sáinz de la Cuesta R; Izquierdo M; Cañamero M; Granizo JJ; Manzarbeitia F
Eur J Obstet Gynecol Reprod Biol; 2004 Mar; 113(1):87-93. PubMed ID: 15036718
[TBL] [Abstract][Full Text] [Related]
13. WT1 expression in endometrioid ovarian carcinoma with and without associated endometriosis.
Stewart CJ; Brennan BA; Chan T; Netreba J
Pathology; 2008 Oct; 40(6):592-9. PubMed ID: 18752126
[TBL] [Abstract][Full Text] [Related]
14. p53 mutations and overexpression affect prognosis of ovarian endometrioid cancer but not clear cell cancer.
Okuda T; Otsuka J; Sekizawa A; Saito H; Makino R; Kushima M; Farina A; Kuwano Y; Okai T
Gynecol Oncol; 2003 Mar; 88(3):318-25. PubMed ID: 12648581
[TBL] [Abstract][Full Text] [Related]
15. Malignant transformation of endometriosis and genetic alterations of K-ras and microsatellite instability.
Amemiya S; Sekizawa A; Otsuka J; Tachikawa T; Saito H; Okai T
Int J Gynaecol Obstet; 2004 Sep; 86(3):371-6. PubMed ID: 15325855
[TBL] [Abstract][Full Text] [Related]
16. Comparative immunohistochemical studies of bcl-2 and p53 proteins in benign and malignant ovarian endometriotic cysts.
Nezhat F; Cohen C; Rahaman J; Gretz H; Cole P; Kalir T
Cancer; 2002 Jun; 94(11):2935-40. PubMed ID: 12115382
[TBL] [Abstract][Full Text] [Related]
17. Unraveling the two entities of endometrioid ovarian cancer: a single center clinical experience.
Mangili G; Bergamini A; Taccagni G; Gentile C; Panina P; Viganò P; Candiani M
Gynecol Oncol; 2012 Sep; 126(3):403-7. PubMed ID: 22609111
[TBL] [Abstract][Full Text] [Related]
18. Distinct β-catenin and PIK3CA mutation profiles in endometriosis-associated ovarian endometrioid and clear cell carcinomas.
Matsumoto T; Yamazaki M; Takahashi H; Kajita S; Suzuki E; Tsuruta T; Saegusa M
Am J Clin Pathol; 2015 Sep; 144(3):452-63. PubMed ID: 26276776
[TBL] [Abstract][Full Text] [Related]
19. [Endometriosis-related ovarian tumors].
Schmidt D; Ulrich U
Pathologe; 2014 Jul; 35(4):348-54. PubMed ID: 24992974
[TBL] [Abstract][Full Text] [Related]
20. Molecular genetic defects in endometriosis.
Thomas EJ; Campbell IG
Gynecol Obstet Invest; 2000; 50 Suppl 1():44-50. PubMed ID: 11093061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
